The cell-free system is a tool that harnesses the complex biological processes outside of
living cells. Owing to the system's superior flexibility and manipulability, it has matured its …

Cardiovascular diseases, such as myocardial infarction, ischemic stroke, and pulmonary
embolism, are the most common causes of disability and death worldwide. Blood clot …

Fibrinolytic enzymes cleave fibrin which plays a crucial role in thrombus formation which
otherwise leads to cardiovascular diseases. While different fibrinolytic enzymes have been …

Sonothrombolysis with recombinant tissue plasminogen activator (rtPA) and microbubbles
has been widely studied to enhance thrombolytic potential. Here, we report different …

Context: Current investigations illustrate the increasing prevalence of atherosclerosis (AS)
through the aggravating role of inappropriate lifestyle patterns. Atherosclerosis is the cause …

Background Recombinant tissue plasminogen activator (rtPA) has a short half-life, and
additional hemorrhagic transformation (HT) can occur when treatment is delayed. Here, we …

Since Nirenberg and Matthaei used cell-free protein synthesis (CFPS) to elucidate the
genetic code in the early 1960s [1], the technology has been developed over the course of …

Diagnostic tests can dramatically improve and save lives. Survival rates and patient
outcomes related to cancer and other diseases can be improved when routine testing …

Humans are starting to explore extreme environments such as space due to advancements
in Science and Technology. Although current manned missions have involved short …

Cell engineering presents great potential for next-generation biotechnological and
biomedical applications that employ engineered mammalian cells to sense intracellular or …